Orbifloxacin
From Infogalactic: the planetary knowledge core
File:Orbifloxacin.png | |
Systematic (IUPAC) name | |
---|---|
1-Cyclopropyl-7-[(3s,5r)-3,5-dimethylpiperazin-1-yl]-5,6,8-trifluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration |
Oral |
Identifiers | |
CAS Number | 113617-63-3 |
ATCvet code | QJ01MA95 (WHO) |
PubChem | CID: 60605 |
ChemSpider | 54631 |
UNII | 660932TPY6 |
KEGG | D08299 |
ChEMBL | CHEMBL295433 |
Chemical data | |
Formula | C19H20F3N3O3 |
Molecular mass | 395.37 g/mol |
|
|
|
|
(what is this?) (verify) |
Orbifloxacin (brand name Orbax) is a fluoroquinolone antibiotic which is approved for use in dogs,[1] marketed by Schering-Plough Animal Health.
See also
References
- ↑ Product Abstract - NADA 141-081. Retrieved on June 23, 2008.
<templatestyles src="Asbox/styles.css"></templatestyles>
<templatestyles src="Asbox/styles.css"></templatestyles>